80
45
Growth Score
-7 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
475194
XPose Therapeutics is an early-stage drug discovery company leveraging a cutting-edge approach using experimental information.
Acquired by 
Mid-Atlantic BioTherapeutics
- Ashley Deacon: Co-Founder & VP Structural Biology
- Debanu Das: Co-Founder & CEO
About the Company
XPose Therapeutics is an early-stage drug discovery company leveraging a cutting-edge approach using experimental information on 3D protein-ligand interactions as a starting point to discover and develop target-specific small molecule cancer therapeutics for traditionally “undruggable” targets.
